NCT01927315View on ClinicalTrials.gov

Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2019

Study Completion Date

December 31, 2019

Conditions
DiabetesDiabetic Retinopathy
Interventions
DRUG

Fenofibrate 145 mg

Tablets of Fulcrosupra 145 mg to be taken at 8.00 am daily for 12 weeks.

DRUG

Placebo

Oral Placebo tablets once daily

Trial Locations (1)

35100

University Hospital of Padova, Diabetes Outpatient Clinic, Padua

All Listed Sponsors
collaborator

Azienda Ospedaliera di Padova

OTHER

lead

University of Padova

OTHER

NCT01927315 - Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes | Biotech Hunter | Biotech Hunter